Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Mind Medicine
Mind Medicine
MindMed doses first subject in Phase IIb generalized anxiety disorder trial
Clinical Trials Arena
Mon, 08/29/22 - 10:22 am
Mind Medicine
MM-120
clinical trials
generalized anxiety disorder
MindMed aims for Nasdaq listing after Compass’ magic mushroom-fuelled IPO
Pharmaforum
Tue, 09/22/20 - 12:13 pm
COMPASS Pathways
IPOs
Mind Medicine
psychedelic drugs
magic mushrooms